scholarly journals Abstracts of the European Society of Clinical Pharmacy International Workshop on Malabsorption and Malnutrition, A Challenge for Clinical Pharmacists, 26–27 April 2021

2021 ◽  
Keyword(s):  
Clinical Pharmacy ◽  
European Society ◽  
International Workshop ◽  
Clinical Pharmacists

European Society of Clinical Pharmacists International Workshop on Geriatrics

Aging Health ◽  
2011 ◽  
Vol 7 (4) ◽  
pp. 517-519
Author(s):  
Louise Mallet ◽  
Annemie Somers
Keyword(s):  
European Society ◽  
International Workshop ◽  
Clinical Pharmacists

Major Issues Facing the Pharmaceutical Industry and Their Relationship to Clinical Pharmacy

1984 ◽  
Vol 18 (1) ◽  
pp. 59-61
Author(s):  
Michael A. Riddiough
Keyword(s):  
Pharmaceutical Industry ◽  
Clinical Research ◽  
Clinical Pharmacy ◽  
Positive Interactions ◽  
Drug Selection ◽  
Clinical Pharmacists ◽  
Pharmaceutical Manufacturers ◽  
Selection Decisions ◽  
Industry Needs ◽  
Clinical Drug

There are two major issues that have potential for positive interactions between the industry and clinical pharmacy. These are drug selection and reimbursement, and clinical research. The first issue embodies the drug prescribing process, which has been, until recently, almost the sole purview of physicians. For this reason, pharmaceutical manufacturers have marketed their products primarily to this group. Changes are occurring; other licensed practitioners, including clinical pharmacists, are gaining prescribing authority. Schools of pharmacy have trained several thousand clinical pharmacists over the past decade, while the pharmacology component of medical education and the time devoted to clinical therapeutics either has stagnated or declined during the same period. Meanwhile, drug information has increased and the need to monitor drug selection to curtail costs has widened the opportunities for clinical pharmacists to exert an influence. The pharmaceutical industry needs to recognize the role clinical pharmacists play in drug selection. Drug selection decisions obviously influence drug reimbursement decisions, which influence drug sales, which influence profits. Clinical research is the backbone of a company's financial success and is becoming technologically sophisticated. Companies are becoming aware that many clinical pharmacists are able to collect and analyze clinical drug data as well as, or possibly better than, physicians. Clinical pharmacists can play a significant role in monitoring the safety and efficacy of marketed drugs. Good postmarketing surveillance data collection systems need to be developed.

scholarly journals Evaluation of a clinical pharmacist team-based telehealth intervention in a rural clinic setting: a pilot study of feasibility, organizational perceptions, and return on investment

2020 ◽  
Vol 6 (1) ◽  
Author(s):  
Logan T. Murry ◽  
Christopher P. Parker ◽  
Rachel J. Finkelstein ◽  
Matthew Arnold ◽  
Korey Kennelty
Keyword(s):  
Clinical Pharmacy ◽  
Clinical Pharmacist ◽  
Return On Investment ◽  
Assistance Program ◽  
Medication Discrepancies ◽  
Clinical Pharmacists ◽  
Clinic Setting ◽  
Rural Clinic ◽  
Uncontrolled Diabetes ◽  
Telehealth Intervention

Abstract Background Remote, centralized clinical pharmacist services provided by board-certified clinical pharmacists have been shown to effectively assist in chronic disease management. We assess the feasibility of implementing a pharmacist-led, remote, centralized pharmacy service to improve A1c levels in patient with diabetes in a rural clinic setting. Methods This was a non-randomized pilot and feasibility study. Participants were enrolled in a pharmacist-led telehealth intervention service, with data prior to enrollment used as baseline data for control. To be included, patients needed to have A1c readings of greater than 7% to be considered uncontrolled. A1c changes were reported for two groups based on A1c ranges: between 7 and 10% and ≥ 10%. Clinical pharmacists and clinical pharmacy interns initiated contact with patients via telephone communication and managed the patients remotely. The following outcomes were evaluated: organization perceptions (patients, providers, and clinic staff), changes in A1c, medication discrepancies, impact of an internally operated Patient Assistance Program, and potential return on investment (ROI). Results Fifty-two patients were initially identified and referred to the service with 43 patients consenting to participate in the intervention. Patient and provider survey responses were recorded. In the initial analysis occurring during the first 3 to 5 months of the program, there was considerable improvement in diabetes control as measured by A1c. For patients with uncontrolled diabetes with a baseline A1c > 7% but less than < 10% and ≥ 10%, the intervention resulted in an A1c decrease of 0.57% and 2.55%, respectively. Clinical pharmacists and clinical pharmacy interns identified at least one medication discrepancy in 44% of patients, with number of discrepancies ranging from 1 to 5 per patient. At the conclusion of the study window, 42 potentially billable encounters were documented, which would have generated a net profit of $1140 USD, had they been submitted for reimbursement. Given the potential revenue generation, the service theoretically yields a ROI of 1.4 to 1. Conclusions Initial results suggest that a pharmacist-led telehealth intervention has potential to decrease A1c levels in patients with diabetes, assist in identification of medication discrepancies, provide a positive return on investment for rural clinics, and potentially increase reimbursement for providers and clinics tasked with managing patients with uncontrolled diabetes.

scholarly journals Recommendations for Meeting the Pediatric Patient's Need for a Clinical Pharmacist: A Joint Opinion of the Pediatrics Practice and Research Network of the American College of Clinical Pharmacy and the Pediatric Pharmacy Advocacy Group

2012 ◽  
Vol 17 (3) ◽  
pp. 281-291 ◽  
Author(s):  
Varsha Bhatt-Mehta ◽  
Marcia L. Buck ◽  
Allison M. Chung ◽  
Elizabeth Anne Farrington ◽  
Tracy M. Hagemann ◽  
...  
Keyword(s):  
Clinical Pharmacy ◽  
Health Care Systems ◽  
Pharmacy Education ◽  
Direct Care ◽  
Research Network ◽  
Pediatric Care ◽  
Care Needs ◽  
Clinical Pharmacists ◽  
Care Systems ◽  
Research Initiatives

Children warrant access to care from clinical pharmacists trained in pediatrics. The American College of Clinical Pharmacy Pediatrics Practice and Research Network (ACCP Pediatrics PRN) released an opinion paper in 2005 with recommendations for improving the quality and quantity of pediatric pharmacy education in colleges of pharmacy, residency programs, and fellowships. While progress has been made in increasing the availability of pediatric residencies, there is still much to be done to meet the direct care needs of pediatric patients. The purpose of this Joint Opinion paper is to outline strategies and recommendations for expanding the quality and capacity of pediatric clinical pharmacy practitioners by 1) elevating the minimum expectations for pharmacists entering practice to provide pediatric care; 2) standardizing pediatric pharmacy education; 3) expanding the current number of pediatric clinical pharmacists; and 4) creating an infrastructure for development of pediatric clinical pharmacists and clinical scientists. These recommendations may be used to provide both a conceptual framework and action items for schools of pharmacy, health care systems, and policymakers to work together to increase the quality and quantity of pediatric training, practice, or research initiatives.

Sport and arrhythmias: summary of an international symposium

2007 ◽  
Vol 14 (5) ◽  
pp. 707-714 ◽  
Author(s):  
Franco Giada ◽  
Serge S. Barold ◽  
Alessandro Biffi ◽  
Bruno De Piccoli ◽  
Pietro Delise ◽  
...  
Keyword(s):  
Sudden Death ◽  
Risk Stratification ◽  
International Symposium ◽  
European Society ◽  
Cardiac Arrhythmias ◽  
Exercise Prescription ◽  
International Workshop ◽  
Sport And Exercise ◽  
European Society Of Cardiology

This article is the report of an International Symposium endorsed by the European Society of Cardiology, held within the Venice Arrhythmias 2007: 10th International Workshop on Cardiac Arrhythmias (Venice, October 2007). The topics of the Symposium are the following: how to stratify the risk of sudden death in the athletes; the role of different diagnostic examinations in the risk stratification of sudden death in the athletes; controversies on arrhythmias and sport; and exercise prescription in patients with arrhythmias. Eur J Cardiovasc Prev Rehabil14:707-714 © 2007 The European Society of Cardiology

Clinical pharmacy service practice in a Chinese tertiary hospital

2015 ◽  
Vol 30 (4) ◽  
Author(s):  
Bing Chen ◽  
Jing-Jing Huang ◽  
He-feng Chen ◽  
Bei-ming Xu
Keyword(s):  
Clinical Pharmacy ◽  
Early Stage ◽  
Tertiary Hospital ◽  
Training System ◽  
Pharmacy Service ◽  
Clinical Pharmacy Service ◽  
Therapeutic Drug ◽  
Clinical Pharmacokinetics ◽  
Clinical Pharmacists ◽  
Medication Therapy

AbstractClinical pharmacy service is focused on the rationality and safety of medication therapy. Clinical pharmacists play an important role in designing therapeutic regimen, preventing medication errors, reducing the incidence of adverse drug reaction, and saving medical costs. Although clinical pharmacy service in China is in its early stage, its development is rapid. In this manuscript, the working model of clinical pharmacists in a Chinese tertiary hospital is introduced, including ward rounds, consultation, stewardship of antimicrobial therapy, drug adverse reaction monitoring, therapeutic drug monitoring, clinical pharmacokinetics and pharmacogenetics, and training system. With the efforts of clinical pharmacists, there will be a significant increase in the optimization of medication therapy and a notable reduction in preventable adverse drug events as well as health-care cost in China.

Sign in / Sign up

Export Citation Format

Share Document